此外，研究发现TACC3是一个有效的非小细胞肺癌的预后标志物(8)。
In addition, studies have shown that TACC3 could be useful as a prognostic marker for non-small cell lung cancer (8).
探讨多种肿瘤标志物蛋白芯片检测系统(C鄄12)在鉴别肺癌的临床分期、病理类型和预后评估中的价值。
To evaluate the value of detective system (C-12) of multiple tumor markers protein biochip for clinical staging, pathologic classification and prognostic evaluation in lung cancer.
结论血清s100 B可以用作评估急性颅脑损伤预后的神经化学标志物。
Conclusion Serum S100B can be a clinically practical neurochemical marker to predict prognosis of acute craniocerebral injury.
特定的染色体和融合基因可作为白血病的标志物，对白血病的诊断、预后估计、监测治疗和微小残留白血病等方面具有一定的价值。
The specific chromosome and fusion gene are regarded as marker of leukemia, and helpful in leukemia diagnosis, evaluating prognosis, monitoring of treatment and minima residual leukemia.
结论MMP - 7在胆管癌中的表达情况与胆管癌的一些临床病理参数有关，提示MMP - 7是估价胆管癌预后的良好标志物。
Conclusions The expression of MMP-7 was correlated with some clinicopathologic parameters of BDC, and MMP-7 was a valuable prognostic marker of BDC.
还有一个需要，以确定疾病的易感性的预后指标，生物标志物来监测疾病的进展和改进的技术新疗法的有效性。
There is also a need to identify prognostic markers of disease susceptibility, biomarkers of disease progression and improved technologies to monitor the effectiveness of new therapies.
近年来众多研究发现了许多具有判断卵巢癌预后潜力的标志物，现将近年来的研究进展综述如下。
Recently many studies found out a lot of potential prognostic markers of ovarian carcinoma. We reviewed recent research progress.
《国际肝病》：晚期肝细胞癌预后极差，在本病早期生物标志物病理诊断方面有什么新进展么？
Hepatology Digest: Advanced hepatocellular carcinoma carries a very bad prognosis, what is the latest developments in terms of biomarkers which can detect this pathology during its early stages.
结论：不同临床分期的大肠癌中存在着差异表达蛋白，这些蛋白可能作为大肠癌分子分期和预后的标志物。
Conclusions: Differentail expressed proteins exist in different clinical stage of CRC, which would be as biomarkers for diagnosis and prediction of prognosis of CRC.
探讨端粒酶作为脑膜瘤标志物，在肿瘤良恶性鉴别、恶性程度评估以及预后预测等方面的意义。
Objective To explore telomerase activity in meningiomas and its significance in tumor's classification, evaluation of malignancy and prognosis.
虽然外泌体作为生物标志物用于诊断或预后在转化应用上推进很快，但基于外泌体的癌症诊断和治疗两方面都有很好的前景。
Although exosome biomarkers for diagnosis or prognosis seem to be on the fast track for translational application, both cancer diagnosis and therapy based by exosomes have bright perspectives.
目的：评价肿瘤标志物CA242与CA19 - 9在大肠癌诊断、治疗和预后中的临床意义。
Objective: To investigate the clinical value of CA242 and CA19-9 (tumor marker) in the diagnosis, treatment and prognosis of colorectal cancer.
目的：观察急性单核白血病（AML-M5）止凝血因子标志物的变化，探索AML-M5患者出血机制及这些标志物在疾病诊疗、预后判断中的意义。
Objective:To study the changes of hemostatic molecular markers inacute monoblastic leukemia (AML-M5) for elucidate the mechanism of hemorrhage and its clinical significance.
Dahl说：“总的来讲，这些研究结果支持GLI1作为乳腺癌新的预后生物标志物的作用。”
Dahl said, "Taken together, these results support a role of GLI1 as a new prognostic biomarker in breast cancer."
我们正在从主要是测量标志物和关注预后的时代，向面对众多心衰治疗的方法，如何治疗患者的时代转变。
We are transitioning from an era in which we mostly measured things and looked at outcomes, to what we can use to help us treat people in the face of a multitude of heart failure treatments.
我们正在从主要是测量标志物和关注预后的时代，向面对众多心衰治疗的方法，如何治疗患者的时代转变。
We are transitioning from an era in which we mostly measured things and looked at outcomes, to what we can use to help us treat people in the face of a multitude of heart failure treatments.
应用推荐